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Introduction
Post-operative nausea and vomiting (PONV) 
commonly occurs following anesthesia and leads to 
patient dissatisfaction and discomfort. In certain settings, 
PONV can lead to post-operative complications, 
especially in a patient that cannot tolerate prominent 
heart rate or blood pressure, intrathoracic pressure, or 
central venous pressure.Resources report the frequency 
of PONV at up to 80% in high-risk populations and up to 
30% of the general population. Increased medical costs, 
prolonged hospitalization, and hospital readmission are 
all common in cases of PONV [1]. Many patients usually 
rank PONV above pain in terms of distress [2]. Many 
patients would prefer pain over post-operative nausea 
or vomiting and would absorb the additional cost to avoid 
PONV. As the need for ambulatory surgery increases, the 
prevention of PONV continues to become more important 
to the system-based approach of anesthesiology 
[3]. Clinical research displays that PONV is caused 
principally using inhalational anesthesia and opioid pain 
reliever. Several risk predictors, including a young age, 
female sex, absence of smoking, and a history of motion 
sickness, also rise PONV [4]. Dexamethasone inhibits 
prostaglandins synthesis, which prepares nerves to other 
commonly intricate neurotransmitters in emesis regulator 
[5]. It also may have vital influence in the nucleus tractus 
solitarius through antagonizing receptors such as 5-HT3 
and corticosteroid. Many studies show that there is an 
enhancement of post-discharge recovery quality besides 
reducing nausea, pain, and fatigue by the administration 
of 8 mg dexamethasone preoperatively [6]. Weighing the 
risk–benefit ratio, a new reporting proposes a solitary 
dose of dexamethasone 4–8 mg is harmless when 
used prophylactically for PONV [7]. Pain management 
postoperatively is a chief alarm for clinicians and for 
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Abstract
BACKGROUND: Post-operative nausea and vomiting (PONV) and pain are a common complications of adult 
patients undergoing anesthesia, but the incidence of these complications in patients go through laparoscopic 
cholecystectomy or open appendectomy is unknown.
AIM: We conduct this study for comparing the effect of dexamethasone administration with normal saline and with 
metoclopramide for reducing these undesirable effects.
DESIGN: This was a three-armed, parallel-group, double-blind, and randomized controlled clinical trial.
METHODS: Seventy-two patients of both genders underwent elective surgeries (laparoscopic cholecystectomy or 
open appendectomy), randomly assigned to three groups: A dexamethasone-treated (8 mg) group (Group 1) (n = 
24), normal saline-treated (100 ml) group (Group 2) (n = 24), and metoclopramide-treated (10 mg) group (Group 3) 
(n = 24). All nausea, vomiting, and pain episodes were recorded during 24 h after anesthesia in three time periods: 
0–4, 4–12, and 12–24 h post-anesthesia.
Results: Nausea and vomiting grading scale shows no significant difference when compare dexamethasone (Group 1) 
with normal saline (Group 2), significant difference when compare dexamethasone (Group 1) with metoclopramide 
(Group 3), and also significant difference when compare normal saline (Group 2) with metoclopramide (Group 3). 
Group 1 showed a lower pain score (p < 0.01 and p < 0.0001) compared with pain score recorded by patients of 
Groups 2 and 3, respectively. Besides that, Group 2 also showed a lower pain score (p < 0.0001) compared with pain 
score recorded by Group 3 patients.
CONCLUSION: Dexamethasone has unimportant effect when compare with normal saline, more effectiveness than 
metoclopramide in reducing PONV. However, dexamethasone more effective in reducing pain when comparing with 
normal saline and metoclopramide for patients they underwent laparoscopic cholecystectomy or open appendectomy 
surgery under general anesthesia.
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patients enduring surgery [8]. Post-operative pain not 
only disturbs the patients operative outcome, health, 
and fulfillment from medical care but also directly affects 
the progress of tachycardia, hyperventilation, alveolar 
ventilation reduction, pain, healing wound poorly, and 
insomnia, which sequentially may affect the outcomes 
of operation [9]. Pain is the most public reason of delay 
patients discharge enduring ambulatory surgery, after 
drowsiness, and digestive discomfort (i.e. nausea and 
vomiting) [10]. This study was conducted to evaluate and 
compare the efficacy of a single dose of dexamethasone, 
normal saline, and metoclopramide administered 
intravenously before surgery on PONV and pain in 
patients undergoing cholecystectomy or appendectomy.
Materials and Methods
Study population
This randomized controlled clinical study was 
carried out at the Salah Aden General Hospital and 
Al-Iraq private hospital in Salah Aden Governorate, 
Iraq, from December 2018 to March 2019. Seventy-two 
patients of both genders undergoing elective surgeries 
(laparoscopic cholecystectomy or open appendectomy) 
of 60–120 min duration with an American Society of 
Anesthesiologists physical status classification system 
risk of I or II [11] were assigned randomly to three 
groups: Group 1 involved 24 patients received 8 mg 
dexamethasone (dissolved in 100 ml isotonic normal 
saline [0.9%]) intravenously 30 min before induction of 
anesthesia. Group 2 involved 24 patients received 100 ml 
isotonic normal saline (0.9%) intravenously 30 min before 
induction of anesthesia. Group 3 involved 24 patients 
received 10 mg metoclopramide (dissolved in 100 ml 
isotonic normal saline [0.9%]) intravenously 30 minutes 
before induction of anesthesia. Criteria of exclusion 
involved history of increased blood pressure, diabetes 
mellitus, renal, hepatic, or cardiovascular diseases; 
respiratory diseases; hematologic or digestive tract 
disorders, or both; hypersensitivity of drugs used in this 
study; motion sickness or vertigo; former post-operative 
emesis; pregnant, breastfeeding, or menstruating 
women; and patient administered antiemetic and 
analgesic medications within 24 h previous surgery.
Anesthetic procedure
Totally, procedures were made under the 
alike team of anesthesiologists and surgeons. 
Patients should be not eating for 8 h before surgery, 
and no one was pre-medicated. In the operating 
room, standard five leads electrocardiography, non-
invasive blood pressure, and pulse oximetry were 
attached and baseline hemodynamic parameters 
were monitored. Anesthesia for patients was induced 
with propofol (1.5–2.5 mg/kg) (IV bolus dose) followed 
by IV injection of muscle relaxant of suxamethonium 
(1.5–2.0 mg/kg) and anesthesia was maintained with 
sevoflurane inspiration at 0.5–3% concentration after 
tracheal intubation. All patients were mechanically 
ventilated with O2/air (50/50%), 4 L/min. The 
maintenance sevoflurane dose was modified for 
hemodynamic stability. All over surgery, hydration was 
kept with an infusion of isotonic solution at a speed of 
3 mL/kg–5 mL/kg. All anesthetic maintenance agents 
were ended during the last surgical suture. Manually 
ventilated lungs with 100% oxygen (4 L/min) up to 
spontaneous respiration were attained. Neostigmine 
(0.03 mg/kg) and atropine (0.02 mg/kg) were used 
for antagonize the residual muscle relaxation, and 
the patients were appropriately extubated. No opioid 
was given at end of surgery and in post-anesthesia 
care unit. All patients were removed to post-operative 
recovery and remonitored after extubation. Patients 
remained for the evaluation of potential post-operative 
complications and recovery for at least 1 h.
Data collection
The primary end point of this study was 
the total PONV rate up to 24 h post-anesthesia. 
The secondary end point was incidence of nausea, 
incidence of vomiting, and severity of nausea for 24 
h post-anesthesia. All episodes of nausea, vomiting, 
and pain (whether in the care unit or in the general 
ward) were recorded during 24 h after anesthesia 
in three time periods: 0–4, 4–12, and 12–24 h post-
anesthesia and the grade of PONV episodes was 
scored according to Common Terminology Criteria 
for Adverse Events version 3.0 using the nausea-
vomiting grading scale, while pain was scored using 
visual pain scale after 24 h of anesthesia [12]. 
Additional antiemetic (10 mg metoclopramide) 
was administered intravenously when the nausea 
and vomiting grading score was ≥3, and additional 
paracetamol 15 mg/kg was given intravenously when 
pain score ≥8. All observations were made by the 
same trained nurses when the symptoms appeared. 
Nausea, vomiting, and pain were assessed by the 
same anesthetist by questioning the patient after 
recovery from anesthesia. Neither health-care 
providers (physicians and nurses) nor participants are 
aware of the time of received medications because 
the third party blinded the containers and left the fluid 
containing medication unlabeled (just with coded 
numbers), so the medications are anonymous for 
both health-care providers and participants (patients).
Ethical approval
Approval of the study procedures was obtained 
from the Ethical Committee of Tikrit University, Iraq, 
under number of 1085, and consent was obtained 
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from all patients after explaining the risk involved and 
benefits of the study in their own language.
Statistical analysis
Statistical calculations done using the SPSS 
(version 21), study parameters were expressed as 
mean ± standard deviation. Chi-square test was 
used for comparisons of discrete variables of the 
study groups, while continuous variable (parametric 
values) was evaluated with the one-way ANOVA test 
and independent two samples t-test. p < 0.05 was 
considered statistically significant.
Results
Demographic variables of the study 
groups
Seventy-two patients were enrolled in the study, 
24 in each group, 12 underwent appendectomy, and 
the other 12 underwent cholecystectomy. Insignificant 
Incidence rate of vomiting
Results presented in Figure 2 illustrated the 
incidence of vomiting during the first 24 h after surgery. 
The occurrence of vomiting at 0–4 h interval was seen 
in 2 (8.33%) patients in Group 2 and in 16 (66.66%) 
patients in Group 3, while none of the patients in 
Group 1 had a vomiting episode at this interval. The 
occurrence of vomiting at 4–12 h interval was seen 
in only 1 (4.16%) patient in Group 1 while no patients 
in Groups 2 and 3 had an episode of vomiting at this 
interval. No patients in all study groups had experience 
vomiting during the third interval of 12–24 h.
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Figure 2: Incidence rate of vomiting during the first 24 h after 
operation. Group 1: Patient received dexamethasone (8 mg) (n = 24), 
Group 2: Patient received normal saline (100 ml) (n = 24), and 
Group 3: Patient received metoclopramide (10 mg) (n = 24)
Nausea and vomiting grading
Figure 3 demonstrates the nausea grading 
according to Common Terminology Criteria for Adverse 
Events version 3.0. In Group 1, 15 (62.5%) patients 
did not have an episode of nausea during the first 24 
h after surgery and only 6 (25%) patients had Grade 1, 
2 (8.33%) patients had Grade 2, and only 1 patient 
(4.16%) classified as having Grade 3 on nausea grading 
scale. Besides this, 15 (62.5%) patients in Group 2 had 
Grade 0 and 9 (37.5%) patients had Grade 1 only, and 
no involvement of other grades. However, 4 (16.66%), 
4 (16.66%), and 16 (66.66%) of patients in Group 3 had 
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Figure 1: Incidence rate of nausea during the first 24 h after operation. 
Group 1: Patient received dexamethasone (8 mg) (n = 24), Group 2: 
Patient received normal saline (100 ml) (n = 24), and Group 3: Patient 
received metoclopramide (10 mg) (n = 24)
Table 1: Demographic data of the study groups.
Parameter Group 1 Group 2 Group 3 p value
Age (years) 31.12±13.22 28.33±11.94 36.25±13.80 0.11a
Weight (kg) 69.21±18.29 65.58±19.73 69.95±11.17 0.49a
Height (cm) 158.54±15.15 161.62±18.52 163.83±8.53 0.45a
BMI (kg/m2) 27.27±5.77 24.49±4.2 26.02±3.54 0.12a
Gender, n (%)
Male 10 (41.66%) 7 (29.16%) 8 (33.33%) 0.65b
Female 14 (58.33%) 17 (70.83%) 16 (66.66%)
Smokers, n (%)
Yes 2 (8.34%) 5 (20.84%) 6 (25%) 0.29b
No 22 (91.66%) 19 (79.16%) 18 (75%)
Data expressed as mean±SD for age, weight, height, and BMI and as number (percentage) for others, 
aOne-way ANOVA. bChi-square test
difference was found between the study groups in terms 
of demographic data (age, weight, height, body mass 
index [BMI], gender distribution, and smoking status), 
as shown in Table 1.
Incidence rate of nausea
Results presented in Figure 1 illustrated the 
incidence of nausea during the first 24 h after surgery. 
The frequency of nausea at 0–4 h interval was 6 (25%) 
patients in Group 1 and 7 (29.16%) patients in Group 2, 
while all the patients in Group 3 suffered from nausea 
at this interval. The frequency of nausea at 4–12 h 
interval was 2 (8.33%) patients in Group 1 while no 
patients in Group 2 had an episode of nausea at this 
interval. However, 4 (16.66%) patients in Group 3 had 
an episode of nausea at this interval. No patients in all 
study groups had experience nausea during the third 
interval of 12–24 h.
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Grade 1, Grade 2, and Grade 3, respectively.
Figure 4 demonstrates the vomiting grading 
in Group 1, 23 (95.83%) patients had no episode 
of vomiting during the first 24 h after surgery, and 
only 1 (4.16%) patients had Grade 2. Besides this, 
22 (91.66%) patients in Group 2 had Grade 0 and 
2 (8.33%) patients had Grade 1, and no involvement 
of other grades. However, 13 (54.16%), 2 (8.33%), 
7 (29.16%), and 2 (8.33%) of patients in Group 3 had 
Grade 1, Grade 2, Grade 3, and Grade 4, respectively.
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Figure 4: Vomiting grading scale. Group 1: Patient received 
dexamethasone (8 mg) (n = 24), Group 2: Patient received 
normal saline (100 ml) (n = 24), and Group 3: Patient received I.V. 
metoclopramide (10 mg) (n = 24)
Nausea and vomiting grading scales in 
Figures 3 and 4 show no significant difference when 
compare dexamethasone (Group 1) with normal saline 
(Group 2) in Grade 0 (p > 0.999), Grade 2 (p = 0.457), 
Grade 3 (p = 0.094), and Grade 4 (p = 0.55) but significant 
difference when compare dexamethasone with normal 
saline (Group 2) in Grade 1 only (p = 0.0003) and also 
significant difference when compare dexamethasone 
(Group 1) with metoclopramide (Group 3) in Grade 0 (p 
< 0.0001), Grade 1 (p < 0.0001), Grade 2 (p < 0.0001), 
Grade 3 (p < 0.0001), and Grade 4 (p < 0.0001). In 
addition, there is a significant difference when compare 
normal saline (Group 2) with metoclopramide (Group 3) 
in Grade 0 (p < 0.0001), Grade 1 (p < 0.0001), Grade 2 
(p < 0.0001), Grade 3 (p < 0.0001), and Grade 4 
(p < 0.02).
Incidence rate of pain
Results presented in Figure 5 illustrated the 
incidence of pain during the first 24 h after surgery. 
The incidence of pain at 0–4 h interval was recorded 
in 11 (45.83%) patients in Group 1 and 17 (70.83%) 
patients in Group 2, while all patients in Group 3 had 
pain at this interval. The incidence of pain at 4–12 h 
interval was recorded in 3 (12.5%) patients in Group 1, 
6 (25%) patients in Group 2, and 19 (79.16%) patients 
in Group 3, respectively. Only 2 (8.33%) patients in 
Group 1 had pain during the third interval of 12–24 h, 
while no patients in Groups 2 and 3 had experience 
pain during the third interval of 12–24 h.
Severity of pain
As illustrated in Table 2, significant differences 
(p < 0.0001) in pain score were observed in this study 
and patients in Group 1 showed the lowest pain score 
while patients of Group 3 recorded the highest score. In 
addition, patients in Group 1 showed a lower pain score 
(p < 0.01 and p < 0.0001) compared with pain score 
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Figure 3: Nausea grading scale. Group 1: Patient received 
dexamethasone (8 mg) (n = 24), Group 2: Patient received 
normal saline (100 ml) (n = 24), and Group 3: Patient received 
metoclopramide (10 mg) (n = 24)
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Figure 5: Incidence rate of pain during the first 24 h after operation. 
Group 1: Patient received dexamethasone (8 mg) (n = 24), Group 2: 
Patient received normal saline (100 ml) (n = 24), and Group 3: Patient 
received metoclopramide (10 mg) (n = 24)
Table 2: Pain scores of the study groups. Data expressed as 
mean±SD
Parameter Group 1 Group 2 Group 3 p value
Pain score 2.25 ± 2.131a,b 3.916 ± 2.41b 7.333 ± 1.203 <0.0001*
*One-way ANOVA. aSignificant as compare with Group 2 (independent two samples t-test). bSignificant as 
compare with Group 3 (independent two samples t-test).
recorded by patients of Groups 2 and 3, respectively. 
Besides that, patients in Group 2 also showed a lower 
pain score (p < 0.0001) compared with pain score 
recorded by patients of Group 3.
Discussion
In this study, patient demographics, type of 
surgical procedure, and anesthetic administered were 
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similar between groups. In addition, patients with a 
history of motion sickness or previous post-operative 
emesis had been excluded from the study; hence, the 
difference in incidence of PONV between groups was 
likely attributable to variation in antiemetic drugs. A major 
finding of this study was dexamethasone (8 mg) has the 
same effect to the normal saline (100 ml) in lowering 
the incidence and severity of PONV, but more effective 
than metoclopramide. However, dexamethasone 
more effective in reducing pain and less frequently 
needed analgesics postoperatively compared to 
normal saline and metoclopramide-treated groups. 
The mode of action of dexamethasone was still not 
understood, however, could be attributed to the central 
inhibition of prostaglandin synthesis, changes in the 
permeability of the blood-cerebrospinal fluid barrier to 
serum protein, and/or a decrease in serotonin turnover 
in the central nervous system [10], dexamethasone 
also reduces inflammation at the operative site, then 
reducing the release of inflammatory mediators into the 
circulation [13]. This is also believed to possibly lead 
to less stimulation of the vomiting center in the brain. 
Dexamethasone inhibits the inflammatory response 
by blocking factors such as bradykinin, prostaglandin, 
and leukotrienes, which result in a decreased level of 
inflammation and reduction of the signs and symptoms 
including pain [14]. A study by Emami et al. suggested 
that pre-operative dexamethasone (8 mg) reduces the 
incidence of PONV, pain, and fatigue after laparoscopic 
cholecystectomy and concluded that the employed 
regimen is safe and without apparent side effects [15]. 
Fujii and Nakayama found that dexamethasone (8 mg) 
is effective in reducing the rate of PONV and analgesic 
requirements in adult Japanese patients undergoing 
middle ear surgery [16]. Cho et al. proposed that 
prophylactic administration of 2.5–5 mg dexamethasone 
can reduce the frequency of PONV, lower visual analog 
pain scores, facilitate recovery to home readiness, 
and improve satisfaction in outpatients undergoing 
anorectal surgery [17]. Talebpour et al. concluded that 
dexamethasone-promethazine was more effective 
in reducing PONV and pain than metoclopramide-
promethazine combination in patient undergoing 
laparoscopic gastric placation [18]. Ahsan et al. found a 
combination of ondansetron with dexamethasone more 
efficacious than ondansetron alone in preventing PONV 
after laparoscopic cholecystectomy [19]. Furthermore, 
a systematic review and meta-analysis of randomized 
controlled trials investigated by Fan et al. concluded 
that dexamethasone not only reduces post-operative 
pain scores and post-operative opioids consumption 
within 48 h but also reduces post-operative vomiting 
and effectively reduces length of stay [20]. The above 
result agrees with our result where dexamethasone 
reduces the pain incidence postoperatively but not 
in agreement with our findings about PONV. Ismail 
et al., [21] in one study, suggested that patients 
undergoing laparoscopic cholecystectomy treated with 
pre-induction dexamethasone (5 mg) plus ringer solution 
have less incidence of PONV and pain during the first 
24 h than dexamethasone (5 mg) alone. Hence, this 
outcome strengthens our results about dexamethasone 
effect on PONV. Wang et al. showed that the incidence 
of rescue analgesia in the dexamethasone group 
was lower than in placebo group [22]. Hence, this 
consequence strengthens our results about pain 
prophylaxis effect of dexamethasone administration. 
Metoclopramide is a D2-receptor antagonist and blocks 
H1 and 5-HT3 receptors also. It boosts 5-HT4 receptors 
and upper gastrointestinal tract motility to stimulate 
gastric emptying devoid of affecting gastric, biliary, 
and pancreatic secretion [23]. FDA has been approved 
metoclopramide exactly to treat nausea and vomiting 
in patients with gastroesophageal reflux disease or 
gastroparesis of diabetic by increasing gastric motility. 
It is also used for controlling nausea and vomiting in 
chemotherapy patients. In addition, metoclopramide 
prophylactically administered to inhibit nausea and 
vomiting in post-operative patients [6]. Our study reveals 
metoclopramide less effective than dexamethasone and 
normal saline in reducing nausea incidence, this finding 
comes in agreement with Kashifard et al. that found 
ondansetron more/effective than metoclopramide in 
reducing nausea incidence. Furthermore, Isazadehfar 
et al. study shows that ondansetron has more effect 
than metoclopramide in reducing nausea incidence 
after laparoscopic cholecystectomy [24].
Conclusion
Single pre-operative injection of 
dexamethasone (8 mg) was more efficacious in 
reducing pain score than normal saline (100 ml) and 
metoclopramide, additionally, has more effect in 
decreasing PONV incidence when compare to the 
metoclopramide in patients, undergoing surgery with 
general anesthesia.
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